These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 14755680)

  • 1. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic guide to the mechanisms of antiestrogen action.
    MacGregor JI; Jordan VC
    Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA; Wang Y; Cunha GR
    Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].
    Maudelonde T; Brouillet JP; Pujol P
    Contracept Fertil Sex; 1999 Sep; 27(9):620-4. PubMed ID: 10540506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens in health and disease.
    Davis SR; Dalais FS; Simpson ER; Murkies AL
    Recent Prog Horm Res; 1999; 54():185-210; discussion 210-1. PubMed ID: 10548876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
    Wang J; Eltoum IE; Lamartiniere CA
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct molecular conformations of the estrogen receptor alpha complex exploited by environmental estrogens.
    Bentrem D; Fox JE; Pearce ST; Liu H; Pappas S; Kupfer D; Zapf JW; Jordan VC
    Cancer Res; 2003 Nov; 63(21):7490-6. PubMed ID: 14612550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL; McNulty AM; Chedid M; Chen K; Goode RL; Johnson MA; Jones CD; Krishnan V; Lynch R; Osborne HE; Graff JR
    Cancer Res; 2003 Sep; 63(18):6056-62. PubMed ID: 14522935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.